Lilly’s Covid-19 antibody combo EUA expands for post-exposure prophylaxis
The authorisation comes after the US Government resumed the supply of bamlanivimab and etesevimab together.

The authorisation comes after the US Government resumed the supply of bamlanivimab and etesevimab together.
Covis Group has agreed to acquire biopharmaceutical company AMAG Pharmaceuticals for a total consideration of about $647m, or $13.75…
Gilead Sciences and Eisai have received approval from the Japanese Ministry of Health, Labour and Welfare (MHLW) for Jyseleca…
Novartis has faced delay in expansion of indication for its spinal muscular atrophy (SMA) drug Zolgensma (onasemnogene abeparvovec) after…
Sanofi and GlaxoSmithKline (GSK) have signed a deal with the Government of Canada to supply up to 72 million…
Japan's Fujifilm Toyama Chemical plans to seek approval for its anti-viral drug Avigan (favipiravir) to treat patients with Covid-19,…
Scenic Biotech has entered into a multi-year strategic partnership with Roche unit Genentech in a bid to discover, develop…
Bausch Health has signed an agreement to acquire an option to buy biopharmaceutical company Allegro Ophthalmics’ ophthalmological assets.
South Korea-based biopharmaceutical services provider Samsung Biologics has signed a long-term supply agreement, valued at approximately $330.8m, with AstraZeneca.
Thank you for subscribing to Pharmaceutical Technology